Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NicoDrops, Inc. is a consumer healthcare company specializing in the development and marketing of nicotine-free smoking cessation aids. Its flagship product, NicoDrops, is an herbal dietary supplement in lozenge form designed to alleviate the stress and cravings associated with quitting smoking without the use of nicotine or other drugs. The company's formulation utilizes natural herbal ingredients to provide a non-addictive alternative to traditional nicotine replacement therapies (NRTs). Based in California and publicly traded on the OTC market, NicoDrops targets broad retail distribution through drug stores, health food outlets, and international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nicodrops.